placebo for 10 weeks

2 trials

Sponsors

Vice chancellor for research, Kurdistan University of Medical Sciences, INTERMUNE PHARMACEUTICALS, INC.,

Conditions

methamphetamine dependence. mental and behavioral disorders due to use of other stimulants, dependence syndrome

Phase 3

Topiramate in the treatment of methamphetamine dependence

Active, not recruitingIRCT201302251556N52

Vice chancellor for research, Kurdistan University of Medical Sciencesmethamphetamine dependence. mental and behavioral disorders due to use of other stimulants, dependence syndrome

Start: 2013-03-05Target: 70Updated: 2018-02-22

Unknown Phase

PHASE III RANDOMIZED DOUBLE BLIND CONTROLLED WITH PLACEBO STUDY DOSAGE ABOUT THE SECURITY AND ANTIMICTIC ACTIVITY OF INTERFERON AND 1B (RIFN AND 1B) RECOMBINANT SUBCUTAIN IN COMBINATION WITH STANDARD THERAPY IN PATIENTS WITH ACUTE CRYTOCOCOCCAL MENINGITIS

Active, not recruitingPER-026-00

INTERMUNE PHARMACEUTICALS, INC.,

Updated: 2023-09-04